Anatomic, not ischemic, burden predicts poor outcomes in CAD

January 20, 2014
Anatomic, not ischemic, burden predicts poor outcomes in CAD

(HealthDay)—For patients with coronary artery disease treated with optimal medical therapy (OMT), anatomic, but not ischemic, burden predicts poor outcomes, according to a study published online Jan. 15 in the Journal of the American College of Cardiology: Cardiovascular Interventions.

G.B. John Mancini, M.D., from the University of British Columbia in Vancouver, Canada, and colleagues studied 621 patients enrolled in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation trial with baseline quantitative nuclear single photon emission computed tomography and quantitative coronary angiography. Independent predictors of death, myocardial infarction (MI), and non-ST-segment elevation (NSTE-ACS) were examined in several multiple regression models.

The researchers found that anatomic burden and left ventricular ejection fraction were consistent predictors of death, MI, and NSTE-ACS in both nonadjusted and adjusted regression models, while ischemic burden and treatment assignment did not predict outcomes. The interaction term of anatomic and ischemic burden had a marginal effect (P = 0.03) for the prediction of clinical outcome, but neither anatomy nor ischemia interacted with therapeutic strategy to predict outcome, either separately or in combination.

"In a cohort of patients treated with OMT, anatomic burden was a consistent predictor of death, MI, and NSTE-ACS, whereas ischemic burden was not," the authors conclude.

More than one author disclosed financial ties to pharmaceutical companies, several of which provided funding for the study.

More information: Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Stories

Registry questions superiority of bivalirudin over heparin

May 22, 2013

Results from a large observational study reported at EuroPCR 2013 today question whether bivalirudin is superior to heparin in the absence of GPIIb/IIIa blockade, showing similar 30-day mortality in patients with non-ST segment ...

ACR: TNF inhibitors linked to reduced risk of ACS in RA

October 29, 2013

(HealthDay)—For patients with rheumatoid arthritis (RA), tumor necrosis factor inhibitor (TNFi) treatment correlates with reductions in the risk of acute coronary syndromes (ACS) and myocardial infarction (MI), according ...

New criteria IDs clinically relevant post-procedure MI

October 31, 2013

(HealthDay)—A new definition of myocardial infarction (MI) that encompasses clinically relevant MI following coronary revascularization, rather than one that identifies small degrees of myonecrosis, should be adopted, according ...

Criteria issued for tests for stable ischemic heart disease

December 19, 2013

(HealthDay)—Appropriate use criteria have been released for tests used to diagnose or evaluate stable ischemic heart disease, in a document published online Dec. 16 in the Journal of the American College of Cardiology. ...

Recommended for you

Heart attack treatment hypothesis 'busted'

July 6, 2015

Researchers have long had reason to hope that blocking the flow of calcium into the mitochondria of heart and brain cells could be one way to prevent damage caused by heart attacks and strokes. But in a study of mice engineered ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.